Glutathione S-transferase-mediated mutagenicity of trihalomethanes in Salmonella typhimurium: Contrasting results with bromodichloromethane and chloroform

Toxicology and Applied Pharmacology

Volumn 144, Issue 1, 1997, Pages 183-188

  Pegram, Rex A ^a   Andersen, Melvin E ^a   Warren, Sarah H ^a   Ross, Tracey M ^a   Claxton, Larry D ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMODICHLOROMETHANE; CHLOROFORM; GLUTATHIONE TRANSFERASE; TRIHALOMETHANE;

ARTICLE; DISINFECTION; DRUG MECHANISM; GENOTOXICITY; MUTAGENICITY; NONHUMAN; SALMONELLA TYPHIMURIUM;

RODENTIA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0031149578     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8123     Document Type: Article

References (43)

1. Andersen M. E., Clewell H. J. III, Gargas M. L., Smith F. A., Reitz R. H. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87:1987;185-205.
2. Bowman F. J., Borzelleca J., Munson A. E. The toxicity of some halomethanes in mice. Toxicol. Appl. Pharmacol. 44:1978;213-215.
3. Butterworth B. E., Popp J. A., Conolly R. B., Goldsworthy T. L. Chemically-induced cell proliferation in carcinogenesis. Mechanisms of Carcinogenesis in Risk Identification. 1992;. p. 279-305.
4. Cantor K. P., Hoover R., Mason T. J., McCabe J. L. Associations of cancer mortality with halomethanes in drinking water. J. Natl. Cancer Inst. 4:1978;979-985.
5. Chu I., Secours V., Marino I., Villeneuve D. C. The acute toxicity of four trihalomethanes in male and female rats. Toxicol. Appl. Pharmacol. 52:1980;351-353.
6. Colacci A., Bartoll S., Bonora B., Guldotti L., Lattanzi G., Mazzullo M., Niero A., Perocco P., Silingardi P., Grilli S. Chloroform bioactivation leading to nucleic acids binding. Tumori. 77:1991;285-290.
7. Corley R. A., Mendrala A. L., Smith F. A., Staats D. A., Gargas M. L., Conolly R. B., Andersen M. E., Reitz R. H. Development of a physiologically based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol. 103:1990;512-527.
8. Dechert S., Dekant W. The possible role ofS. Toxicologist. 30:1996;93.
9. Dunnick J. K., Eustis S. L., Lilja H. S. Bromodichloromethane, a trihalomethane that produces neoplasms in rodents. Cancer Res. 47:1987;5189-5193.
10. Fujie K., Aoki T., Wada M. Acute and subacute cytogenetic effects of the trihalomethanes on rat bone marrow cellsin vivo. Mutat. Res. 242:1990;111-119.
11. Graves R. J., Coutts C., Green T. Methylene chloride-induced DNA damage: An interspecies comparison. Carcinogenesis. 16:1995;1919-1926.
12. Graves R. J., Green T. Mouse liver glutathioneS. Mutat. Res. 367:1996;143-150.
13. Graves R. J., Trueman P., Jones S., Green T. DNA sequence analysis of methylene chloride-induced HPRT mutations in Chinese hamster ovary cells: Comparison with the mutation spectrum obtained for 1,2-dibromoethane and formaldehyde. Mutagenesis. 11:1996;229-233.
14. 1313. Chem. Res. Toxicol. 7:1994;291-296.
15. Hughes T. J., Simmons D. M., Monteith L. G., Claxton L. D. Vaporization technique to measure mutagenic activity of volatile organic chemicals in the Ames/Salmonella. Environ. Mutagen. 9:1987;421-441.
16. Environmental Health Criteria 163: Chloroform. 1994.
17. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 1991;IARC, Lyon.
18. Jorgenson T. A., Meierhenry E. F., Rushbrook C. J., Bull R. J., Robinson J. Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 5:1985;760-769.
19. Koch W. H., Henrikson E. N., Kupchella E., Cebula T. A. Salmonella typhimurium. Carcinogenesis. 15:1994;79-88.
20. Krasner S. W., McGuire M. J., Jacangelo J. G., Patania N. L., Reagan K. M., Aieta E. M. The occurrence of disinfection by-products in U.S. drinking water. J. Am. Water Works Assoc. 81:1989;41-53.
21. Kroll R. B., Robinson G. D., Chung J. H. Characterization of trihalomethane (THM)-induced renal dysfunction in the rat. II. Relative potency of THMs in promoting renal dysfunction. Arch. Environ. Contam. Toxicol. 27:1994;5-7.
22. Larson J. L., Wolf D. C., Butterworth B. E. Acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 20:1993;302-315.
23. Larson J. L., Wolf D. C., Butterworth B. E. Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: Comparison of administration by gavage in corn oil vsad libitum. Fundam. Appl. Toxicol. 22:1994a;90-102.
24. Larson J. L., Wolf D. C., Butterworth B. E. Induced cytolethality and regenerative cell proliferation in the livers and kidneys of male B6C3F1 mice given chloroform by gavage. Fundam. Appl. Toxicol. 23:1994b;537-543.
25. Lilly P. D., Andersen M. E., Pegram R. A. A physiologically-based pharmacokinetic description of bromodichloromethane tissue dosimetry and metabolism. Toxicologist. 30:1996;251.
26. Lilly P. D., Simmons J. E., Pegram R. A. Dose-dependent vehicle differences in the acute toxicity of bromodichloromethane. Fundam. Appl. Toxicol. 23:1994a;132-140.
27. 3. Toxicologist. 14:1994b;280.
28. Maron D. M., Ames B. N. Revised methods for theSalmonella. Mutat. Res. 113:1983;173-215.
29. Meyer D. J., Coles B., Pemble S. E., Gilmore K. S., Fraser M., Ketterer B. Theta, a new class of glutathione transferases purified from rat and man. Biochem. J. 247:1991;409-414.
30. Morris R. D., Audet A., Angelillo I. F., Chalmers T. C., Mosteller F. Chlorination, chlorination by-products, and cancer: A meta-analysis. Am. J. Public Health. 7:1992;955-963.
31. National Cancer Institute, 1976, Report on the Carcinogenesis Bioassay of Chloroform, NCI, Bethesda, MD.
32. Toxicology and Carcinogenesis Studies of Bromodichloromethane in F344/N Rats and B6C3F1 Mice (Gavage Studies). 1987.
33. Pohl L. R., Bhooshan B., Whittaker N. F., Krishna G. Phosgene: A metabolite of chloroform. Biochem. Biophys. Res. Commun. 79:1977;684-691.
34. Reitz R. H., Mendrala A. L., Corley R. A., Quast J. F., Gargas M. L., Andersen M. E., Staats D. A., Conolly R. B. Estimating the risk of liver cancer associated with human exposures to chloroform. Toxicol. Appl. Pharmacol. 105:1990;443-459.
35. Rosenthal S. A review of the mutagenicity of chloroform. Environ. Mol. Mutagen. 10:1987;199-205.
36. Schroder K. R., Hallier E., Peter H., Bolt H. M. Dissociation of a new glutathione S-transferase activity in human erythrocytes. Biochem. Pharmacol. 43:1992;1671-1674.
37. 1. Carcinogenesis. 14:1993;1371-1376.
38. Testai E., Di Marzio S., Vittozzi L. Multiple activation of chloroform in hepatic microsomes from uninduced B6C3F1 mice. Toxicol. Appl. Pharmacol. 104:1990;496-503.
39. Thier R., Taylor J. B., Pemble S. E., Humphreys W. G., Persmark M., Ketterer B., Guengerich F. P. Expression of mammalian glutathioneSSalmonella typhimurium. Proc. Natl. Acad. Sci. USA. 90:1993;8576-8580.
40. Thier R., Pemble S. E., Kramer H., Taylor J. B., Guengerich F. P., Ketterer B. Human glutathioneSSalmonella typhimurium. Carcinogenesis. 17:1996;163.
41. Thornton-Manning J. R., Seely J. C., Pegram R. A. Toxicity of bromodichloromethane in female rats and mice after repeated oral dosing. Toxicology. 94:1994;3-18.
42. Tomasi A., Albano E., Biasi F., Slater T. F., Vannini V., Dianzani M. U. Activation of chloroform and related trihalomethanes to free radical intermediates in isolated hepatocytes and in the rat in vivo as detected by the ESR-spin trapping technique. Chem.-Biol. Interact. 55:1985;303-316.
43. U.S. Environmental Protection Agency, 1994, Drinking Water Criteria for Trihalomethanes, Office of Water, U.S. EPA.